BioGX, Inc. is a global molecular diagnostics company that has been focused on the health and safety
of communities all over the world from its inception in 2007, originally developing tests for Water
Quality, Food Safety and Pharma Quality Control. The company has since grown into a formidable
contender in the molecular diagnostics industry, leading the way for simple yet superior molecular
diagnostics testing.

Sweet Home Alabama
Headquartered in Alabama, USA, BioGX’s American footprint allows for the manufacture of customdesigned, platform agnostic Sample-Ready™ reagents for Laboratory Developed Tests (USA
only). Using real-time PCR, BioGX makes molecular testing easy for labs with its novel SampleReady™ approach to LDTs, which enable a lab to specify its choice of test and receive a highperformance mix of all the necessary reagents, primers and probes, lyophilized and in one tube
without the need for refrigeration. The proprietary Sample-Ready™ technology is at the core of the
company’s worldwide offerings across clinical, food safety, pharma and water quality testing.

A Global Reach
Wholly owned subsidiary, BioGX BV, is located in Amsterdam, The Netherlands and boasts a large
portfolio of CE-IVD marked tests, spread across a wide variety of infectious diseases ranging from
COVID-19, respiratory to sexual health, enteric pathogens, drug resistance, meningitis, transplant and
tropical disease. With our Global Partnership Initiative, we can supply the rest of the world with our
products, fast and effectively.
All BioGX reagents are fine-tuned to ensure the highest performance in any lab setting, even outer
space, where our products are currently used in the International Space Station. Through continuous
innovation our team of scientists aim to make RT-PCR as simple, robust and efficient for laboratories
all over the world.

Expertise: CE-IVD marked tests, spread across a wide variety of infectious diseases